Charles L. Wiseman

2.4k total citations
53 papers, 1.8k citations indexed

About

Charles L. Wiseman is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Charles L. Wiseman has authored 53 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 20 papers in Immunology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Charles L. Wiseman's work include Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Charles L. Wiseman is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Charles L. Wiseman collaborates with scholars based in United States, United Kingdom and Switzerland. Charles L. Wiseman's co-authors include Kun Liao, Ami Radunskaya, L. G. de Pillis, Cary A. Presant, Douglas W. Blayney, Victor Waluch, Kirit Gala, Karen M. Butler, M. Ernest Marshall and George R. Blumenschein and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Charles L. Wiseman

51 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles L. Wiseman United States 19 680 467 425 424 343 53 1.8k
Schabel Fm United States 23 941 1.4× 766 1.6× 251 0.6× 155 0.4× 81 0.2× 60 2.1k
N. J. McNally United Kingdom 19 614 0.9× 837 1.8× 661 1.6× 157 0.4× 46 0.1× 46 2.2k
Harry K. Slocum United States 27 1.1k 1.6× 1.0k 2.2× 479 1.1× 185 0.4× 26 0.1× 71 2.4k
John M. Venditti United States 26 1.0k 1.5× 1.1k 2.4× 397 0.9× 137 0.3× 34 0.1× 91 2.6k
Skipper He United States 18 512 0.8× 446 1.0× 204 0.5× 94 0.2× 61 0.2× 37 1.2k
R. E. Durand Canada 21 558 0.8× 753 1.6× 1.5k 3.4× 364 0.9× 41 0.1× 38 2.6k
Mariaelena Pierobon United States 25 971 1.4× 1.4k 3.1× 581 1.4× 267 0.6× 39 0.1× 82 2.5k
Kenneth Kolinsky United States 19 1.3k 1.9× 1.3k 2.8× 294 0.7× 197 0.5× 25 0.1× 33 2.3k
Dinesh P. de Alwis United States 21 900 1.3× 517 1.1× 182 0.4× 75 0.2× 74 0.2× 37 1.6k
Jon Holmlund United States 24 537 0.8× 1.1k 2.3× 184 0.4× 164 0.4× 23 0.1× 55 1.7k

Countries citing papers authored by Charles L. Wiseman

Since Specialization
Citations

This map shows the geographic impact of Charles L. Wiseman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles L. Wiseman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles L. Wiseman more than expected).

Fields of papers citing papers by Charles L. Wiseman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles L. Wiseman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles L. Wiseman. The network helps show where Charles L. Wiseman may publish in the future.

Co-authorship network of co-authors of Charles L. Wiseman

This figure shows the co-authorship network connecting the top 25 collaborators of Charles L. Wiseman. A scholar is included among the top collaborators of Charles L. Wiseman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles L. Wiseman. Charles L. Wiseman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chumsri, Saranya, Chaitali Nangia, Minal Barve, et al.. (2025). Bria-IMT + checkpoint inhibitor: Phase I/II survival results compared to benchmark trials in metastatic breast cancer.. Journal of Clinical Oncology. 43(16_suppl). 1096–1096.
2.
3.
Pillis, L. G. de, Ami Radunskaya, & Charles L. Wiseman. (2007). Comment on: A Validated Mathematical Model of Cell-Mediated Immune Response to Tumor Growth. Cancer Research. 67(17). 8420–8420. 5 indexed citations
4.
5.
Wiseman, Charles L., et al.. (2003). Phorbol myristate acetate and Bryostatin 1 rescue IFN-gamma inducibility of MHC class II molecules in LS1034 colorectal carcinoma cell line. Cancer Cell International. 3(1). 4–4. 13 indexed citations
6.
Presant, Cary A., Walter Wolf, Victor Waluch, et al.. (2000). Enhancement of Fluorouracil Uptake in Human Colorectal and Gastric Cancers by Interferon or by High-Dose Methotrexate: An In Vivo Human Study Using Noninvasive 19F-Magnetic Resonance Spectroscopy. Journal of Clinical Oncology. 18(2). 255–255. 22 indexed citations
7.
Presant, Cary A., Victor Waluch, Douglas W. Blayney, et al.. (1994). Association of intratumoral pharmacokinetics of fluorouracil with clinical response. The Lancet. 343(8907). 1184–1187. 134 indexed citations
8.
Wiseman, Charles L., Cary A. Presant, Renuka Rao, & John Kelly Smith. (1993). Clinical Responses to Intralymphatic Whole‐Cell Melanoma Vaccine Augmented by in Vitro Incubation with Alpha‐Interferona. Annals of the New York Academy of Sciences. 690(1). 388–391. 2 indexed citations
9.
Ajani, Jaffer A., Richard Pazdur, Rodger J. Winn, et al.. (1991). Phase II study of intravenous 6-thioguanine in patients with advanced gastric carcinoma. Investigational New Drugs. 9(3). 257–259. 3 indexed citations
10.
Presant, Cary A., Douglas W. Blayney, Peter G. E. Kennedy, et al.. (1990). Preliminary report: imaging of Kaposi sarcoma and lymphoma in AIDS with indium-111-labelled liposomes. The Lancet. 335(8701). 1307–1309. 58 indexed citations
11.
Presant, Cary A., Walter Wolf, Kenneth L. Servis, et al.. (1990). Human tumor fluorouracil trapping: clinical correlations of in vivo 19F nuclear magnetic resonance spectroscopy pharmacokinetics.. Journal of Clinical Oncology. 8(11). 1868–1873. 62 indexed citations
12.
Presant, Cary A., Richard T. Proffitt, Alison Turner, et al.. (1988). Successful imaging of human cancer with indium-111-labeled phospholipid vesicles. Cancer. 62(5). 905–911. 69 indexed citations
13.
Presant, Cary A., Charles L. Wiseman, Kirit Gala, et al.. (1987). Antiemetic effects of metoclopramide (M) continuous infusion (CI): safety, efficacy, patient preference, and cost reduction.. PubMed. 248. 299–302. 2 indexed citations
14.
Marshall, M. Ernest, et al.. (1987). Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: a pilot study.. Journal of Clinical Oncology. 5(6). 862–866. 87 indexed citations
15.
Hortobágyi, G. N., H. Y. Yap, George R. Blumenschein, et al.. (1983). Phase II evaluation of vinblastine, methotrexate, and calcium leukovorin rescue in patients with refractory metastatic breast cancer. Cancer. 51(5). 769–772. 5 indexed citations
16.
Wiseman, Charles L., Hwee‐Yong Yap, Agop Y. Bedikian, Gerald P. Bodey, & George R. Blumenschein. (1982). Phase II trial of bruceantin in metastatic breast carcinoma. American Journal of Clinical Oncology. 5(4). 389–392. 27 indexed citations
17.
Wiseman, Charles L., et al.. (1982). Inflammatory breast cancer treated with surgery, chemotherapy and allogeneic tumor cell/BCG immunotherapy. Cancer. 49(6). 1266–1271. 28 indexed citations
18.
Wiseman, Charles L., et al.. (1980). Human Lymphocyte Blastogenesis Responses to Mouse Mammary Tumor Virus<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>. JNCI Journal of the National Cancer Institute. 64(3). 425–30. 7 indexed citations
19.
Pathak, Sen, Michael J. Siciliano, Relda Cailleau, Charles L. Wiseman, & Tsai‐Ching Hsu. (1979). A Human Breast Adenocarcinoma With Chromosome and Isoenzyme Markers Similar to Those of the Hela Line<xref ref-type="fn" rid="fn2">2</xref>. JNCI Journal of the National Cancer Institute. 62(2). 263–71. 53 indexed citations
20.
Wiseman, Charles L. & Kun Liao. (1972). Primary lymphoma of the breast. Cancer. 29(6). 1705–1712. 358 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Schabel Fm Breakdown of academic impact, for papers by N. J. McNally Breakdown of academic impact, for papers by Harry K. Slocum Breakdown of academic impact, for papers by John M. Venditti Breakdown of academic impact, for papers by Skipper He Breakdown of academic impact, for papers by R. E. Durand Breakdown of academic impact, for papers by Mariaelena Pierobon Breakdown of academic impact, for papers by Kenneth Kolinsky Breakdown of academic impact, for papers by Dinesh P. de Alwis Breakdown of academic impact, for papers by Jon Holmlund
Rankless by CCL
2026